Skip to main content
. 2019 Jun 5;5(1):e000905. doi: 10.1136/rmdopen-2019-000905

Figure 6.

Figure 6

Kaplan-Meier curve representing vasculitis relapse-free survival (months) after starting rituximab (log-rank test). Estimation was limited to the largest survival time evaluated (36 months after starting treatment), p=0.82 (log-rank test). ANCA, antineutrophil cytoplasmic antibodies.